About PMV Pharma
PMV Pharma is a company based in Cranbury (United States) founded in 2013 by Thomas Shenk and Arnold Levine.. PMV Pharma has raised $236 million across 4 funding rounds from investors including Orbimed, RA Capital and Avoro Capital Advisors. The company has 47 employees as of December 31, 2024. PMV Pharma operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others.
- Headquarter Cranbury, United States
- Employees 47 as on 31 Dec, 2024
- Founders Thomas Shenk, Arnold Levine
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pmv Pharmaceuticals, Inc.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-58.71 M14.87as on Dec 31, 2024
-
EBITDA
$-84.3 M-6.88as on Dec 31, 2024
-
Total Equity Funding
$236 M (USD)
in 4 rounds
-
Latest Funding Round
$70 M (USD), Series D
Aug 03, 2020
-
Investors
Orbimed
& 12 more
-
Employee Count
47
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of PMV Pharma
PMV Pharma is a publicly listed company on the NASDAQ with ticker symbol PMVP in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of PMV Pharma
PMV Pharma has successfully raised a total of $236M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $70 million completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series D — $70.0M
-
First Round
First Round
(02 Dec 2014)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2020 | Amount | Series D - PMV Pharma | Valuation | Avoro Capital Advisors , RA Capital Management | |
| Nov, 2019 | Amount | Series C - PMV Pharma | Valuation | Nextech Invest | |
| Mar, 2017 | Amount | Series B - PMV Pharma | Valuation | Euclidean Capital , Topspin Fund |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PMV Pharma
PMV Pharma has secured backing from 13 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Orbimed, RA Capital and Avoro Capital Advisors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund focused on biotechnology startups
|
Founded Year | Domain | Location | |
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
PE firm investing in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PMV Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PMV Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pmv Pharma Comparisons
Competitors of PMV Pharma
PMV Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pmv Pharma
Frequently Asked Questions about PMV Pharma
When was PMV Pharma founded?
PMV Pharma was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is PMV Pharma located?
PMV Pharma is headquartered in Cranbury, United States. It is registered at Cranbury, New Jersey, United States.
Who is the current CEO of PMV Pharma?
David H Mack is the current CEO of PMV Pharma.
Is PMV Pharma a funded company?
PMV Pharma is a funded company, having raised a total of $236M across 4 funding rounds to date. The company's 1st funding round was a Series B of $74M, raised on Dec 02, 2014.
How many employees does PMV Pharma have?
As of Dec 31, 2024, the latest employee count at PMV Pharma is 47.
What does PMV Pharma do?
PMV Pharmaceuticals is a US-based, early-stage biotech developing p53 targeting small molecule therapeutics for cancer. The company was co-founded by Dr. Arnold Levine, one of the discoverers of the p53 protein. The protein, p53 plays a pivotal role in the bodys natural defense mechanism against cancer and induces a highly-organized program of cellular death to prevent the proliferation of potentially cancerous cells. The company hasnt disclosed its drug programs as of Aug.2017.
Who are the top competitors of PMV Pharma?
PMV Pharma's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
Is PMV Pharma publicly traded?
Yes, PMV Pharma is publicly traded on NASDAQ under the ticker symbol PMVP.
Who are PMV Pharma's investors?
PMV Pharma has 13 investors. Key investors include Orbimed, RA Capital, Avoro Capital Advisors, Wellington, and Nextech Invest.
What is PMV Pharma's ticker symbol?
The ticker symbol of PMV Pharma is PMVP on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.